Athanase Innovation AB (SE:ATIN)
:ATIN
ATIN Stock Chart & Stats
kr18.00
kr1.00(5.56%)
At close: 4:00 PM EST
kr18.00
kr1.00(5.56%)
Day’s Range― - ―
52-Week Rangekr10.00 - kr24.80
Previous CloseN/A
Volume58.00
Average Volume (3M)56.00
Market Cap
kr277.89M
Enterprise Valuekr32.50M
Total Cash (Recent Filing)kr245.39M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta0.45
Next Earnings
May 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.44
Shares Outstanding19,297,642
10 Day Avg. Volume41
30 Day Avg. Volume56
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.81
Price to Sales (P/S)9.42
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetNear-zero leverage materially reduces solvency and refinancing risk, giving management time and optionality to execute a turnaround or invest incrementally. Over 2-6 months this flexibility supports stability and lowers probability of distress despite weak operations.
Lean Operating Footprint (31 Employees)A small headcount implies a lower fixed-cost base and operational flexibility, which can extend runway while management focuses on stabilizing revenue or cutting discretionary spend. This structural nimbleness aids survival during multi-quarter restructurings.
Low Market Sensitivity (low Beta)A low beta indicates limited correlation with broader market swings, which can help preserve capital and reduce volatility in earnings expectations. For an asset manager with weak near-term results, lower systemic risk supports steadier planning and fundraising efforts.
Bears Say
Severe Revenue DeclineA multi-year, sharp revenue contraction undermines fee generation and economies of scale intrinsic to asset management. Sustained declines erode client confidence and pricing power, making recovery harder and requiring meaningful business-model fixes to restore durable growth.
Recurring Losses And Weak MarginsPersistent negative gross and net margins indicate the core business is not generating profit even before financing costs. Ongoing losses erode equity and limit internal reinvestment capacity, forcing dependence on external capital or asset sales to fund operations long term.
Negative Operating Cash FlowConsistent OCF deficits consume liquidity and shorten the operational runway. Even with low leverage, sustained negative cash generation forces management into dilutive financing or asset reductions, constraining strategic choices and risking service disruption to clients.
ATIN FAQ
What was Athanase Innovation AB’s price range in the past 12 months?
Athanase Innovation AB lowest stock price was kr10.00 and its highest was kr24.80 in the past 12 months.
What is Athanase Innovation AB’s market cap?
Athanase Innovation AB’s market cap is kr277.89M.
When is Athanase Innovation AB’s upcoming earnings report date?
Athanase Innovation AB’s upcoming earnings report date is May 12, 2026 which is in 44 days.
How were Athanase Innovation AB’s earnings last quarter?
Athanase Innovation AB released its earnings results on Feb 20, 2026. The company reported -kr0.437 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.437.
Is Athanase Innovation AB overvalued?
According to Wall Street analysts Athanase Innovation AB’s price is currently Overvalued.
Does Athanase Innovation AB pay dividends?
Athanase Innovation AB pays a Quarterly dividend of kr289.504 which represents an annual dividend yield of N/A. See more information on Athanase Innovation AB dividends here
What is Athanase Innovation AB’s EPS estimate?
Athanase Innovation AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Athanase Innovation AB have?
Athanase Innovation AB has 19,297,642 shares outstanding.
What happened to Athanase Innovation AB’s price movement after its last earnings report?
Athanase Innovation AB reported an EPS of -kr0.437 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Athanase Innovation AB?
Currently, no hedge funds are holding shares in SE:ATIN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Athanase Innovation AB
Athanase Innovation AB is an alternative investment firm in Sweden. It invests in companies that operate in the forefront of robotics, digitalization, and automation. The company was incorporated in 2016 and is based in Stockholm, Sweden.